Correlation Between Dupont De and Petros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dupont De and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Petros Pharmaceuticals, you can compare the effects of market volatilities on Dupont De and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Petros Pharmaceuticals.
Diversification Opportunities for Dupont De and Petros Pharmaceuticals
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dupont and Petros is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Dupont De i.e., Dupont De and Petros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dupont De and Petros Pharmaceuticals
Allowing for the 90-day total investment horizon Dupont De is expected to generate 4.07 times less return on investment than Petros Pharmaceuticals. But when comparing it to its historical volatility, Dupont De Nemours is 8.29 times less risky than Petros Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 31.00 in Petros Pharmaceuticals on October 20, 2024 and sell it today you would lose (1.00) from holding Petros Pharmaceuticals or give up 3.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.0% |
| Values | Daily Returns |
Dupont De Nemours vs. Petros Pharmaceuticals
Performance |
| Timeline |
| Dupont De Nemours |
| Petros Pharmaceuticals |
Dupont De and Petros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Petros Pharmaceuticals
The main advantage of trading using opposite Dupont De and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Olin Corporation | Dupont De vs. Cabot | Dupont De vs. Kronos Worldwide |
| Petros Pharmaceuticals vs. Sunshine Biopharma | Petros Pharmaceuticals vs. Sonoma Pharmaceuticals | Petros Pharmaceuticals vs. Alpha Teknova | Petros Pharmaceuticals vs. Evoke Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |